GlobalData on MSN
NG Biotech announces FDA approval for diagnostic assays
NG Biotech manufactured the assays in France, with Hardy Diagnostics serving as the exclusive distributor in the US.
Diagnosing a dangerous infection by a fungal yeast that often devastates hospital patients is now faster and more efficient. The new blood test has the potential to improve patient outcomes, as the ...
Over the last year, Dr Ghannoum has been making some serious noise in the world of digestive health, by explaining that gut health isn’t just about bacteria, but fungi as well. That’s right, you have ...
SANTA MARIA, Calif. and GUIPRY, France, Feb. 18, 2026 /PRNewswire/ -- In a major step forward against Antimicrobial ...
LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...
The FDA reviewed T2Candida through its de novo classification process for certain novel low-to-moderate-risk medical devices. In a clinical study, T2Candida demonstrated a sensitivity of 91.1% and ...
What Are the Symptoms of Invasive Candidiasis? People who have other medical conditions are often at risk of getting invasive candidiasis. It can be difficult to tell which symptoms are caused by ...
Roche’s cobas® BV/CV PCR assay aims to address frequent misdiagnosis of bacterial vaginosis and Candida vaginitis. The duplex test detects both conditions from one swab with high specificity, enabling ...
A new, rapid test for Candida infections of the bloodstream may cut mortality from 40% to 11%, according to a report published in the April 24 issue of Science Translational Medicine. Lori A. Neely, ...
According to the CDC, it can "colonize" people without them being aware.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results